🇺🇸 FDA

Drug profile · INN

valsartan

DILART

FDA: approved TGA: approved NMPA: clinical trials
US status
approved
Patents linked
2
News articles
0

Quick answer

valsartan (DILART) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN valsartan
Brand DILART
Route ORAL
Formulation CAPSULE
Originator Alphapharm Pty Ltd

Related patents

Search patents →

  1. US 10689352

    Solid state forms of trisodium valsartan: sacubitril

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8729115

    Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is valsartan?

valsartan (DILART) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for valsartan?

DILART is a marketed brand name for valsartan. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of valsartan?

valsartan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.